DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,015 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,916,523 | +17.7% | 7,671 | +17.7% | 0.19% | +8.7% |
Q1 2024 | $1,627,754 | -10.1% | 6,518 | -16.7% | 0.17% | -14.9% |
Q4 2023 | $1,811,205 | -3.7% | 7,829 | +3.3% | 0.20% | -13.7% |
Q3 2023 | $1,880,290 | +282.0% | 7,579 | +269.5% | 0.23% | +271.4% |
Q2 2023 | $492,260 | +0.2% | 2,051 | +5.2% | 0.06% | -3.1% |
Q1 2023 | $491,339 | -8.8% | 1,949 | -4.0% | 0.06% | -13.3% |
Q4 2022 | $538,959 | +1.9% | 2,031 | -0.9% | 0.08% | -9.6% |
Q3 2022 | $529,000 | -2.0% | 2,049 | -3.8% | 0.08% | +1.2% |
Q2 2022 | $540,000 | -7.1% | 2,129 | +7.5% | 0.08% | +6.5% |
Q1 2022 | $581,000 | +1.2% | 1,981 | +13.6% | 0.08% | +5.5% |
Q4 2021 | $574,000 | +3.8% | 1,744 | -4.0% | 0.07% | -3.9% |
Q3 2021 | $553,000 | +12.2% | 1,816 | -1.1% | 0.08% | +13.4% |
Q2 2021 | $493,000 | +28.1% | 1,836 | +5.9% | 0.07% | +17.5% |
Q4 2020 | $385,000 | +4.6% | 1,734 | +1.4% | 0.06% | -8.1% |
Q3 2020 | $368,000 | +28.2% | 1,710 | +5.4% | 0.06% | +21.6% |
Q2 2020 | $287,000 | +82.8% | 1,622 | +43.2% | 0.05% | +41.7% |
Q1 2020 | $157,000 | -11.8% | 1,133 | -2.2% | 0.04% | -29.4% |
Q4 2019 | $178,000 | -8.2% | 1,159 | -13.8% | 0.05% | -13.6% |
Q3 2019 | $194,000 | +1.0% | 1,345 | +0.1% | 0.06% | -7.8% |
Q2 2019 | $192,000 | +814.3% | 1,344 | +552.4% | 0.06% | +700.0% |
Q4 2018 | $21,000 | -4.5% | 206 | 0.0% | 0.01% | -11.1% |
Q3 2018 | $22,000 | +4.8% | 206 | -5.1% | 0.01% | 0.0% |
Q2 2018 | $21,000 | +90.9% | 217 | +79.3% | 0.01% | +50.0% |
Q1 2018 | $11,000 | +22.2% | 121 | +24.7% | 0.01% | +50.0% |
Q4 2017 | $9,000 | +28.6% | 97 | +5.4% | 0.00% | +33.3% |
Q3 2017 | $7,000 | +250.0% | 92 | +318.2% | 0.00% | +200.0% |
Q2 2017 | $2,000 | +100.0% | 22 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -50.0% | 22 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $2,000 | – | 22 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |